Table 1.
Demographic characteristics of PD and non-neurological control group study participants
| Control | PD Total | PD Drug näive | PD Treated | |
|---|---|---|---|---|
| N of cases | 87 | 52 | 30 | 22 |
| Gender M/F % | 68/32 | 69/31 | 73/27 | 64/36 |
| Age (years) | 61.5 ± 10.2 | 63.9 ± 10.5 | 63.6 ± 11.8 | 64.3 ± 9 |
| MoCA scores (44/52) | NA | 23.5 ± 4.3 | 24.4 ± 4.1 | 22.4 ± 4.4 |
| Hoehn & Yahr scale (48/52) | NA | 2.0 ± 0.9 | 1.7 ± 0.9 | 2.3 ± 0.4 |
| Disease duration(y) | NA | – | 8.25 (1–18) | |
| Medication (LED) | NA | – | 790 (160–1741) |
Demographic characteristics for non-neurological control and the whole as well as the stratified PD group are presented. Age, MoCA scores and Hoehn and Yahr scale is presented as mean ± SD. Disease duration is presented in years while medication is presented as L-dopa equivalent doses (LEDs). Disease duration and medication is presented as mean with lowest and highest values in parenthesis.